Evidence map›Paper›PMID 41490492›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2026

Constitutively high levels of endogenous soluble ST2 inhibit food allergic responses in mice.

Mayuki Kojima, Kumi Izawa, Tomoaki Ando, Keiko Maeda, Ayako Kaitani, Nobuhiro Nakano, Risa Yamamoto, Shunichi Miyazaki, Mayu Shinagawa, Mio Sasaki and 13 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Mayuki KojimaAtopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.ORCID 0000-0002-0979-8077
Kumi IzawaAtopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.ORCID 0000-0003-4746-7225
Tomoaki AndoAtopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.ORCID 0000-0002-8548-4424
Keiko MaedaAtopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.
Ayako KaitaniAtopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.
Nobuhiro NakanoAtopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.ORCID 0000-0002-5317-5950
Risa YamamotoAtopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.
Shunichi MiyazakiAtopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.
Mayu ShinagawaAtopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.
Mio SasakiAtopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.
Anna KameiAtopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.
Akie MaeharaAtopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.
Naoko NegishiAtopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.ORCID 0000-0003-3091-8157
Hiromichi YamadaAtopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.
Shino UchidaAtopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.
Eisuke InageDepartment of Pediatrics and Adolescent Medicine, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.
Yoshikazu OhtsukaDepartment of Pediatrics and Adolescent Medicine, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.ORCID 0000-0002-8109-084X
Susumu NakaeGraduate School of Integrated Sciences for Life, Hiroshima University, Hiroshima 739-8528, Japan.ORCID 0000-0002-8988-0256
Hideoki OgawaAtopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.
Ko OkumuraAtopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.
Hiromichi ShojiDepartment of Pediatrics and Adolescent Medicine, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.
Toshiaki ShimizuAtopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.ORCID 0000-0003-0364-0022
Jiro KitauraAtopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.ORCID 0000-0002-5083-8368

Funding

A Grant-in-Aid for Special Research in Subsides for ordinary expenses of private schools from The Promotion and Mutual Aid Corporation for Private Schools of Japan 2023JSPS KAKENHI 20H03721 23H02946 and 22K11887Nipponham Foundation (Nipponham Foundation for the Future of Food) 2023
6 · The paper itself

Abstract

IL-33-induced signals via membrane-bound ST2 (ST2L) are critical for allergies. However, the physiological role of endogenous soluble ST2 (sST2) remains elusive. Here, we generated sST2-deficient mice with intact ST2L using the CRISPR/Cas9 system. Skin fibroblasts constitutively released sST2 protein at extremely high levels compared to mast cells, which did not reflect the expression levels of sST2 mRNA. This discrepancy can be partly explained by the sST2 protein degradation mediated by mast cell proteases. Accordingly, sST2 deficiency did not affect IL-33- and/or IgE plus antigen-stimulated mast cell activation in vitro. We provided evidence that constitutively high levels of sST2 suppress food allergies in mice by inhibiting IL-33-dependent, both expansion of jejunum mast cells and enhancement of their degranulation. Analysis of bone marrow chimeric mice under steady-state conditions showed that circulating sST2 was derived almost equally from hematopoietic and nonhematopoietic cells. Increased circulating sST2 in food-allergic mice was possibly and partly derived from fibroblasts stimulated by locally released IL-4 and IL-13. In conclusion, endogenous sST2 contributes to the suppression of food allergies.

Indexed as

Food HypersensitivityInterleukin-1 Receptor-Like 1 ProteinAnimalsCell DegranulationFibroblastsImmunoglobulin EInterleukin-13Interleukin-33Interleukin-4JejunumMast CellsMiceMice, Inbred C57BLMice, KnockoutSkinIl1rl1 protein, mouseIl33 protein, mouseImmunoglobulin EInterleukin-13Interleukin-1 Receptor-Like 1 ProteinInterleukin-33Interleukin-4fibroblastfood allergyIL-33mast cellsoluble ST2

Identifiers

PMID41490492
PMCPMC12799158

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.